The latest closing stock price for Neurogene as of November 20, 2024 is 15.33.
An investor who bought $1,000 worth of Neurogene stock at the IPO in 2014 would have $-936 today, roughly -1 times their original investment - a -22.10% compound annual growth rate over 11 years.
The all-time high Neurogene stock closing price was 442.60 on August 14, 2015.
The Neurogene 52-week high stock price is 74.49, which is 385.9% above the current share price.
The Neurogene 52-week low stock price is 12.49, which is 18.5% below the current share price.
The average Neurogene stock price for the last 52 weeks is 35.47.
An investor who bought $1,000 worth of Neurogene stock at the IPO in 2014 would have $-936 today, roughly -1 times their original investment - a -22.10% compound annual growth rate over 11 years.
The all-time high Neurogene stock closing price was 442.60 on August 14, 2015.
The Neurogene 52-week high stock price is 74.49, which is 385.9% above the current share price.
The Neurogene 52-week low stock price is 12.49, which is 18.5% below the current share price.
The average Neurogene stock price for the last 52 weeks is 35.47.